CD86 and chronic obstructive pulmonary disease: Compared with controls, BALF mDCs of current smokers with COPD were characterized by an increased expression of CD1a, BDCA-1, Langerin, BDCA-4, MMR and CD86 (Figures 3, 4 and Table 2).